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The ventral pallidum (VP) is crucially involved in reward processing. Dopaminergic
afferents reach the VP from the ventral tegmental area (VTA). Recent in vivo studies
suggest dopamine application increase the firing in the VP. However, little is known
about the cellular effects of dopamine within the VP. We aimed to address this paucity
of data using brain slices containing the VP and multi-electrode array recordings.
Dopamine significantly affected firing in 86% of spontaneously active VP neurons.
Among the affected neurons, 84% were excited, while 16% were inhibited. The selective
D1-like receptor agonist SKF81297 also had modulatory effects on the majority of VP
neurons, but its effects were universally excitatory. On the other hand, the D2-like
receptor agonist quinpirole had modulatory effects on 87% of VP neurons studied. It
caused significant inhibitory effects in 33% of the cases and excitatory effects in the
remaining 67%. The effects of D1-like receptor activation were presynaptic as blocking
synaptic transmission with low Ca2+ abolished the effects of SKF81297 application.
Furthermore, SKF81297 effects were abolished by blocking ionotropic glutamate
receptors, suggesting that D1-like receptors boost glutamate release, which in turn
excites VP neurons through postsynaptic glutamate receptors. Effects caused by
D2-like receptor activation were found to involve pre and postsynaptic mechanisms,
as low Ca2+ abolished the excitatory effects of quinpirole but not the inhibitory ones.
Increases in firing frequency (ff) to quinpirole application were abolished by a group
2/3 mGluR antagonist, suggesting that D2-like receptors cause presynaptic inhibition
of glutamate release, resulting in reduced postsynaptic activation of inhibitory mGluRs.
Conversely, the inhibitory effects of quinpirole persisted in low Ca2+ and therefore can be
attributed to postsynaptic D2-like receptor activation. VP neurons excited by dopamine
had shorter spike half-widths and are excited by D1-like receptors (presynaptically) and
by D2-like receptors (postsynaptically). VP neurons inhibited by dopamine have longer
spike half-widths and while D1-like receptor activation has a presynaptic excitatory
influence on them, D2-like receptor activation has a postsynaptic inhibitory effect that
prevails, on balance. These data provide novel insights into the cellular mechanisms by
which dopamine controls information processing within the VP.
Keywords: ventral pallidum, dopamine, multielectrode, reward, basal ganglia
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INTRODUCTION
The ventral pallidum (VP) is a key output structure for the
ventral striatum (Smith et al., 2009). It also forms multiple
feedback loops with some of the key structures involved in
reward signaling, including the nucleus accumbens (NAc),
the medial pre-frontal cortex, the basal lateral amygdala, the
subthalamic nucleus and the ventral tegmental area (VTA;
Root et al., 2015). The VP is known to have populations
of GABAergic interneurons and cholinergic neurons that
belong to the forebrain magnocellular cholinergic system
(Gritti et al., 1993; Pang et al., 1998; Bengtson and Osborne,
2000).
Interest in the VP has increased recently as the VP, and its
connective circuitry, is heavily associated with reward, aspects
of reinforcement and motivational salience (Cromwell and
Berridge, 1993; Itoga et al., 2016; Richard et al., 2016). Indeed
Smith et al. (2009) conclude that it is an essential integrative
region for reward and reward learning and may well be a
‘‘limbic final common pathway.’’ The VP also plays a key
role in addictive behavior towards drugs of abuse (Hubner
and Koob, 1990; Hiroi and White, 1993; Robledo and Koob,
1993; Gong et al., 1996; Fletcher et al., 1998; Tang et al.,
2005).
The VP has a substantial dopaminergic projection arising
from the VTA (Klitenick et al., 1992; Smith and Kieval, 2000;
Root et al., 2015) and dopamine receptor subtypes (D1, D2,
D3) are known to be expressed within the VP (Mansour
et al., 1990; Richtand et al., 1995). However, little is known
about the effects of dopamine in the VP. Heidenreich et al.
(1995) have shown that, in vivo, D1-like receptor agonists
increase the firing frequency (ff) in approximately 45% of VP
neurons. Napier and Maslowski-Cobuzzi (1994) found that
D2-like receptor agonists also modulated the firing frequency in
the VP in vivo and Johnson and Napier (1997) suggested that
dopamine effects depend on modulation of GABA inputs into
VP. However, the cellular mechanisms activated by dopamine
in the VP are still obscure. In vivo experiments are not
ideal to clarify this issue, as the concentrations of ligands
cannot be precisely controlled and because the presence of
multiple active inputs to both the VP and the dopaminergic
neurons in the VTA, greatly complicate the interpretation of the
results.
Elucidating the cellularmechanisms underlying the dopamine
action in the VP is an extremely important aim, as there is
a strong connection between dopamine and the role of the
VP in reward and addictive behavior. Recently, manipulation
of dopamine in the VP has been shown to dramatically affect
avoidance learning. Péczely et al. (2014) and Lénárd et al.
(2017) have shown that D1-like and D2-like receptors within
the VP are involved in the formation and retention of avoidance
learning. Further, research (Maslowski and Napier, 1991b; Stout
et al., 2016) has illustrated the role of dopamine in the VP
on the effects of drugs of abuse. Creed et al. (2016) have
suggested that targeted research on the VP is essential as
it may provide novel strategies to treat addiction/addictive
disorders.
MATERIALS AND METHODS
Animals
This study was carried out in accordance with the
recommendations of the UK Home Office’s Animals (Scientific
Procedures) Act 1986. The protocol was approved by the local
Sheffield University Ethics Committee. Extracellular in vitro
recordings were obtained from C57 mice. In some instance,
due to availability, mice from the transgenic line ChR2-NNos
(Jackson Laboratory, Bar Harbor, ME, USA) were used. No
differences were found in the electrophysiological activity of VP
neurons between these animals and the C57 mice.
Slice Preparation
Mice aged between 28 days and 42 days were killed by cervical
dislocation and death confirmed by decapitation. The brain was
rapidly removed from the skull and parasagittal slices of 400 µm
obtained using a vibroslicer (Cambden Instruments) immersed
in ice cold (5◦C), oxygenated (saturated 95% O2 and 5% CO2)
sucrose cutting solution. This solution was made up fresh daily
and contained (inmM): Sucrose (184), KCl (2.5), NaH2PO4 (1.2),
NaHCO3 (30), HEPES (20), Glucose (25), sodium ascorbate
(5), Thiourea (2), sodium pyruvate (3), MgSO4.7H2O (10),
CaCl2.2H2O (0.5).
Once cut, slices were immediately transferred to a recovery
chambermaintained at 26◦C, containing a Tris recovery solution,
which was continuously aerated with a carbogen mixture of
95% O2 and 5% CO2 gas. The Tris recovery solution was made
up fresh daily and contained (in mM): Tris HCl (76), Tris
base (19.5), KCl (2.5), NaH2PO4 (1.2), NaHCO3 (30), HEPES
(20), Glucose (25), sodium ascorbate (5), Thiourea (2), sodium
pyruvate (3), MgSO4.7H2O (10), CaCl2.2H2O (0.5). The slices
remained in this chamber for 30 min, before being transferred to
another chamber for storage. This chamber was also maintained
at 26◦ C and contained standard aCSF, which was continuously
aerated with a carbogen mixture of 95% O2 and 5% CO2 gas.
The standard aCSF was also made up fresh daily and contained
(in mM): NaCl (124), KCl (3), NaH2PO4 (1.2), NaHCO3 (26),
Glucose (15), MgSO4 (2), CaCl2 (2). The slices were then left
for a minimum of 60 min to equilibrate and recover before
electrophysiological recordings commenced.
pMEA (Perforated Multi-Electrode Array)
Electrophysiological Recordings
Neural network activity was monitored and recorded using
a perforated multi-electrode array (pMEA, Multi-Channel
Systems, Reutlingen, Germany). The pMEA contained
60 embedded electrodes constructed of titanium nitrite.
Each of these electrodes has a diameter of 30 µm and they
are spaced at 200 µm. Recorded electrical activity for selected
channels of interest was digitized at a sampling rate of 10 kHz
using a MEA1060-Up-BC amplifier and MC_Rack (version:
4.6.2) software (Multi-Channel Systems, Reutlingen, Germany).
For recording slices were transferred to the pMEA chamber,
already in position in the amplifier. Once the slice was moved
into position over the electrodes on the MEA, the bottom flow
Frontiers in Cellular Neuroscience | www.frontiersin.org 2 August 2018 | Volume 12 | Article 260
Clark and Bracci Dopamine Effects in Ventral Pallidum
was switched on to produce suction and fix the slice into position.
A mesh harp was then placed on top of the slice and a top flow
applied as quickly as possible to maintain healthy slices. Both the
top and bottom flow (perfusion) contained continuously aerated
aCSF. The bottom flow rate was maintained at 0.65–1 ml/min
and the top flow was maintained at 3–5 ml/min. Activity was
monitored for 1 h before recordings commenced.
Depending upon the experimental protocol, two types of
aCSF were used to perfuse the slice once in the MEA recording
chamber. One referred to as standard aCSF/control and a second
with low Ca2+ levels referred to as low Ca2+ aCSF. The standard
aCSF contained (in mM): NaCl (124), KCl (3), NaH2PO4 (1.2),
NaHCO3 (26), Glucose (15), MgSO4.7H2O (2), CaCl2.2H2O (2).
The low Ca2+ aCSF was the same as the ‘‘standard’’ aCSF, bar a
reduced quantity of CaCl2 (0.2 mM).
Slice Visualization
To identify the correct area of the mouse slice for recording of
the VP neurons, the pMEA was placed in the amplifier and then
under an Olympus BX51 microscope, with a 4× lens. The slice
was viewed via a Tucson digital microscope camera, which was
sending a live feed to a Viglen computer (4 gb of memory and an
i5 processor) running IS capture software.
Pharmacology
All drugs were obtained from either Tocris Biosciences (UK) or
Sigma Aldrich and were bath applied into the header reservoir
feeding the top perfusion flow of the pMEA at the following
concentrations:
1. 4aR-trans)-4,4a,5,6,7,8,8a,9-Octahydro-5-propyl-1H-pyrazolo
[3,4-g]quinoline hydrochloride: (-)-Quinpirole hydrochloride
(quinpirole), 20 µM.
2. (±)-6-Chloro-2,3,4,5-tetrahydro-1-phenyl-1H-3-
benzazepine hydrobromide: (SKF81297), 20 µM.
3. (S)-(-)-5-Aminosulfonyl-N-[(1-ethyl-2-pyrrolidinyl)methyl]-
2-methoxybenzamide (sulpiride), 20 µM.
4. (6aS-trans)-11-Chloro-6, 6a, 7, 8, 9, 13b-hexahydro-7-methyl-
5H-benzo[d]naphth[2,1-b]azepin-12-olhydrobromide
(SCH39166), 20 µM.
5. 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo[f]quinoxaline-2,
3-dione (NBQX), 20 µM.
6. D-(-)-2-Amino-5-phosphonopentanoic acid (AP5), 20 µM.
7. (RS)-α-Methyl-4-carboxyphenylglycine (MCPG), 20 µM.
8. (RS)-α-Methyl-4-sulfonophenylglycine (MSPG), 10 µM.
9. 3, 4-Dihydroxyphenethylamine hydrochloride: (dopamine),
30 µM.
Washout of any pharmacological treatment was considered
complete when firing frequency recorded over a period of 1,200 s
was not significantly different from that observed over a 1,200 s
period just before drug application.
Data Analysis
Data was acquired using MC_Rack software (version: 4.6.2)
and a MEA1060-Up-BC amplifier (Multi-Channel Systems,
Reutlingen, Germany). These files (.mcd) were then converted
to .ced files using multichannel data manager software (version:
1.9.7, Multi-Channel Systems, Reutlingen, Germany) for off-line
analysis using Spike 2 software (C.E.D).
For all recordings, spike sorting was carried out offline
using dedicated Spike2 (C.E.D.) software. This software uses an
automated waveform matching system to construct waveform
templates and allows the user to set an appropriate threshold
for detection of individual units. When multiple units were
detected in a trace, discrete clustering of waveforms within a
template was verified through principal components analysis,
also implemented by Spike2.
See figure legends for information on result expression.
All error bars are expressed as SEM. In order to assess
differences in a neuron’s firing frequency in different
pharmacological conditions, we measured consecutive ISIs
during the final 1,200 s of each condition. Average ISIs for
relevant conditions were then compared using a Student’s
t-test. A statistically significant difference was considered to
be present if P < 0.05. If a treatment caused a significant
increase in ISI, we refer to this observation in the results as
a significant decrease in firing frequency and an inhibitory
effect of the treatment. If a treatment caused a significant
decrease in ISI, we refer to this observation as a significant
increase in firing frequency and an excitatory effect of the
treatment.
Coefficient of variation (CoV) was calculated as a measure
of spike train variability in different pharmacological conditions
and as a potential way of identifying different neuronal types
in the VP. It was calculated as standard deviation (ISI)/Mean
ISI. Threshold for spike detection was considered to be reached
when the recorded voltage departed from baseline (0 mV in AC
recording mode) by more than the standard deviation of the
FIGURE 1 | Spike half-width calculation. (A) A raw data trace of tonic neuronal
activity measured in the ventral pallidum (VP). (B) An example of a typical
spike recorded in the VP with the reference point used for calculation of its
spike half-width, halfway between baseline and maximum negative amplitude.
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voltage recorded for that channel during an apparently quiescent
period (of at least 3 s). Spikes consisted of a biphasic negative-
positive waveform. Spike amplitude was defined as the difference
between the negative voltage peak and the spike threshold level
defined above. Spike half-width was defined as the time the
value of the recorded voltage (measured from the threshold
level) remained more negative than half of the spike amplitude
(Figure 1; Pettersen and Einevoll, 2008).
RESULTS
Dopamine Application Has Dual Effects on
VP Neurons
From six experiments, 35 VP neurons were selected for
analysis as they responded to dopamine application.
29/35 neurons displayed significant (P < 0.05) increases in
firing frequency to application of dopamine (Figures 2A,B)
while 5/35 displayed significant (P < 0.05) decreases in firing
frequency (Figures 2C,D). In the neurons that were excited
by dopamine, the average increase in firing frequency was
78 ± 14% (Figure 2E). In the neurons that were inhibited
by dopamine, the average decrease in firing frequency was
−17± 3% (Figure 2E).
Baseline firing frequency and spike half-width were calculated
for all neurons. Two clusters of neurons, with different spike
half-width profiles can be identified in Figure 2F, those with a
shorter spike half-width (cluster I) in the range 0.12–0.24 ms and
those with a longer spike half-width (cluster II), in the range
0.28–0.36 ms. Those neurons with a shorter spike half-width
(cluster I) are all excited by dopamine, while neurons with a
longer spike half-width (cluster II) show both excitatory and
inhibitory responses to dopamine. The baseline firing frequency
of VP neurons excited by dopamine was not significantly
different (P > 0.05) from that of those inhibited by dopamine
(Figure 2G). However, spike half-width was significantly
(P < 0.05) larger 0.32 ± 0.04 ms in neurons inhibited by
dopamine than in those excited by dopamine 0.19 ± 0.01 ms as
illustrated in Figure 2H.
We concluded that there are two electrophysiologically
distinct populations of VP neurons that could be consistently
differentiated by their spike half-widths. Those with a shorter
half-width (cluster I) were consistently excited by dopamine,
however, for cluster II, some neurons were excited by dopamine
while others were inhibited by dopamine.
Receptors Responsible for Dopamine
Effects on VP Neurons
Mansour et al. (1990) found that D1, D2 and D3 receptors
are present within the VP. To identify the dopamine receptors
involved in excitatory and inhibitory VP neurons responses,
we carried out experiments using D1-like and D2-like receptor
agonists.
In five experiments, 34 VP neurons were selected for
analysis as they responded to application of the D2-like receptor
agonist quinpirole. 28/34 of these neurons displayed significant
(P < 0.05) changes in firing frequency in response to quinpirole
application with, 9/34 displaying significant (P < 0.05)
decreases in firing frequency and 19/34 displaying significant
(P < 0.05) increases in firing frequency in response to quinpirole
application. In a further four experiments, 29 VP neurons were
selected for analysis as they responded to application of the
D1-like receptor agonist SKF81297. 22/29 of these neurons
displayed significant (P < 0.05) increases in firing frequency in
response to SKF81297 application.
In order to further explore the role of dopamine receptor
types, we carried out experiments in which quinpirole and
SKF81297 were applied sequentially (SKF81297 was applied after
complete washout of quinpirole).
From six experiments, 21 VP neurons were identified
for analysis as they responded to quinpirole and
SKF81297 application. Sequential application of quinpirole
and SKF81297 resulted in 13/21 neurons displaying significant
(P < 0.05) increases in firing frequency to both SKF81297 and
quinpirole (Figure 3B). 6/21 neurons displayed significant
(P < 0.05) decreases in firing frequency to quinpirole and
significant (P < 0.05) increases, in firing frequency, to SKF81297
(Figure 3D). This means that 62% of the neurons in the VP
were excited by both SKF81297 and quinpirole, while 29% of
neurons were inhibited by quinpirole but excited by SKF81297
(Figure 3E).
In order to ascertain if the responses to quinpirole and
SKF81297 were produced by distinct types of neurons in the
VP, baseline firing frequency (Figure 3F), CoV (Figure 3G)
and spike half-width (Figure 3H) were measured for neurons
that were excited by both quinpirole and SKF81297 and for
those excited by SKF81297 but inhibited by quinpirole. Baseline
firing frequency and CoV (Figures 3F,G) were not significantly
(P > 0.05) different in the two populations. On the other
hand, there was a significant (P < 0.05) differences in spike
half-width (Figure 3H). Neurons excited by both quinpirole and
SKF81297 had a spike half-width of 0.15 ± 0.08 ms, while those
excited by SKF81297 but inhibited by quinpirole had a spike
half-width of 0.37 ± 0.03 ms. The range of spike half-widths
for these populations was similar to those of cluster I and
cluster II (Figure 2F). Cluster I had a spike half-width range of
0.12–0.24 ms (Figure 2F), which compares well to neurons that
were excited by both quinpirole and SKF81297 that had a spike
half-width range of 0.10–0.22 ms. On the other hand, cluster II
had a spike half-width range of 0.28–0.36 ms (Figure 2F), which
compared well to neurons that were excited by SKF81297 but
inhibited by quinpirole, which had a spike half-width range of
0.27–0.42ms. This suggests that cluster I in Figure 2F correspond
to those neurons excited by both quinpirole and SKF81297
(Figure 3B), while cluster II in Figure 2F correspond to those
neurons excited by SKF81297, but inhibited by quinpirole
(Figure 3D).
We concluded that D1-like and D2-like receptors can cause,
independently, an increase in firing frequency in the majority of
VP neurons, but that an electrophysiologically distinct minority
of neurons, characterized by longer spike half-width durations,
are inhibited by D2-like receptors. Therefore, it appeared likely
the effects of dopamine in the neurons inhibited by D2-like
receptors is depended on the net balance between the excitatory
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FIGURE 2 | Dopamine application has dual effects on VP neurons. (A) Excitatory response to dopamine application in a VP neuron. (B) Changes in firing frequency
(ff) for 30 VP neurons in experiments similar to that illustrated in panel (A). Firing frequency was measured before and during the application of dopamine.
(C) Inhibitory response to dopamine application in a VP neuron. (D) Changes in firing frequency for five VP neurons in experiments similar to those illustrated in panel
(C). Firing frequency was measured before and during the application of dopamine. (E) Distribution of excitatory (yellow) and inhibitory (black) responses (% change
compared to baseline) to dopamine application in VP neurons with their corresponding average values. (F) Spike half-widths (ms) for each neuron compared to %
change in firing frequency in response to dopamine application. (G) Firing frequency for VP neurons excited by dopamine (yellow) and those inhibited (black).
(H) Significant differences in spike half-width (ms) for VP neurons excited by dopamine application (yellow) and those inhibited (black). In this and following figures,
∗P < 0.05 and ∗∗P < 0.01.
influence of D1-like receptors and the inhibitory influence of
D2-like receptors.
Repeated Application of Dopamine and
Dopamine Receptor Agonists
Preliminary experiments showed that application of dopamine
caused strong increases or decreases in firing frequency in VP
neurons. As the following experiments involved pharmacological
protocols with repeated applications of dopamine (or dopamine
receptor agonists) in the presence of different ligands, it
was important to establish whether neuronal responses to
subsequent short applications of dopamine were similar, or
whether significant sensitization or desensitization (Chen et al.,
1996; Otani et al., 1998; Calabresi et al., 2007) were observed.
Dopamine was applied twice (the second application
was carried out after complete washout of the first).
In two experiments, 10 VP neurons were identified for
analysis, as they responded to dopamine. In seven of these
neurons, dopamine significantly (P < 0.05) increased
firing (Figure 4A), while in the other three dopamine
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FIGURE 3 | D1-like receptor agonists excite while D2-like receptor agonists excite and inhibit VP neurons. (A) Excitatory response to the application of quinpirole
and SKF81297 (separated by complete washout out). (B) Changes in firing frequency for 14 VP neurons induced by quinpirole application and SKF81297 application
similar to that illustrated in panel (A). Firing frequency was measured; before the application of quinpirole, after the application of quinpirole and subsequently, after a
period of wash out, for the application of SKF81297. Responses characterized by significant (P < 0.05) changes in firing frequency are in gray, the other ones in
yellow. (C) Inhibitory response to the application of quinpirole and excitatory response to the application of SKF81297 (separated by complete washout).
(D) Changes in firing frequency for seven VP neurons induced by quinpirole application and SKF81297 application similar to that illustrated in panel (C). Firing
frequency was measured; before the application quinpirole, after the application of quinpirole and subsequently, after a period of wash out, for the application of
SKF81297. Responses characterized by significant (P < 0.05) changes in firing frequency are in gray, the other ones in yellow. (E) The majority of neurons analyzed
responded with increases in firing frequency in response to both quinpirole and SKF81297 (yellow), but a minority decreased their firing frequency in response to
quinpirole and increased their firing frequency in response to SKF81297 (black). (F) Firing frequency for those neurons excited by both quinpirole and SKF81297
(yellow) and those neurons that were inhibited by quinpirole (black). (G) Coefficient of variation (CoV) for those neurons excited by both quinpirole and SKF81297
(yellow) and those inhibited by quinpirole (black). (H) Significant differences in spike half-width (ms) for those neurons excited by both quinpirole and SKF81297
(yellow) and those that were inhibited by quinpirole (black).
significantly (P < 0.05) decreased firing (Figure 4B). In
all cases, the second application of dopamine produced
similar effects to the first one, as the firing frequencies
measured during the first and the second application of
dopamine were not significantly different for any of the
10 neurons (Figures 4D,E). We concluded that repeated
exposure to dopamine elicited similar effects in VP neurons
(Figure 4C).
Having established that repeated application of dopamine
caused similar responses in VP neurons, we carried out the same
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FIGURE 4 | Repeated application of dopamine, D1-like receptor agonists and D2-like receptor agonists produce no clear sensitization effects in VP neurons.
(A) Excitatory responses to two similar dopamine applications (separated by complete washout) in a VP neuron. (B) Inhibitory responses to two dopamine
applications in a different VP neuron. (C) Changes in firing frequency for 10 VP neurons induced by repeated dopamine applications similar to that illustrated in
panels (A,B). Firing frequency was measured before the first application of dopamine, during the first application of dopamine, after dopamine wash out and finally
during the second application of dopamine. Responses characterized by significant (P < 0.05) changes in firing frequency are in gray, the other ones in yellow.
(D) Firing frequency during first and second dopamine application for neurons excited by dopamine. (E) Firing frequency during first and second dopamine
application for neurons inhibited by dopamine. (F) Excitatory responses to two quinpirole applications (separated by complete washout) in a VP neuron. (G) Inhibitory
response to two quinpirole applications in a different neuron. (H) Changes in firing frequency for nine VP neurons to the repeated application of quinpirole in
experiments similar to that illustrated in panels (A,B). Firing frequency was measured before the first application of quinpirole, during the application of quinpirole,
after wash out, before the second application of quinpirole and finally during the second application of quinpirole. Responses characterized by significant (P < 0.05)
changes in firing frequency are in gray, the other ones in yellow. (I) Firing frequency changes during first and second application of quinpirole in neurons excited by
quinpirole. (J) Firing frequency changes during first and second application of quinpirole in neurons inhibited by quinpirole application. (K) Excitatory responses to
two applications of SKF81297 (separated by complete washout) in a VP neuron. (L) Changes in firing frequency for seven VP neurons in response to repeated
SKF81297 application in experiments similar to that illustrated in panel (A). Firing frequency was measured; before the first application of SKF81297, during the
application of SKF81297, after wash out, before the second application of SKF81297 and finally during the second application of SKF81297. Responses
characterized by significant (P < 0.05) changes in firing frequency are in gray, the other ones in yellow. (M) Firing frequency changes during first and second
application of SKF81297 for neurons excited by SKF81297 application.
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FIGURE 5 | D1-like and D2-like receptor antagonists modulate the effect of dopamine in the VP. (A) For some neurons, when dopamine was applied in the presence
of sulpiride, it produced a larger increase in firing than when it was applied in the absence of sulpiride. (B) Firing frequency changes to dopamine application in
control and in the presence of sulpiride, for neurons similar to that illustrated in panel (A). (C) For some neurons, when dopamine was applied in the presence of
sulpiride, it produced a smaller increase in firing than when it was applied in the absence of sulpiride. (D) Firing frequency changes to dopamine application in control
and in the presence of sulpiride, for neurons similar to that illustrated in panel (C). (E) Firing frequency changes to dopamine application for neurons that showed a
larger increase in firing to dopamine application (black) in the presence of sulpiride and neurons that showed a smaller increase in firing to dopamine application in
the presence of sulpiride (yellow). (F) CoV for neurons that showed a larger increase in firing to dopamine in the presence of sulpiride (black) and those that showed a
smaller increase in firing to dopamine in the presence of sulpiride (yellow). (G) Significant differences in spike half-width (ms) for neurons that showed a larger
increase in firing to dopamine in sulpiride (black) compared to those that showed a smaller increase in firing to dopamine in sulpiride (yellow). (H) For some neurons,
when dopamine was applied in the presence of SCH39166, it produced a smaller increase in firing than when it was applied in the absence of SCH39166. (I) Firing
frequency changes during dopamine application and dopamine in the presence of SCH39166, for neurons similar to that illustrated in panel (H). (J) Excitatory
responses to dopamine application followed (after complete washout of dopamine) by inhibitory responses to dopamine application in the presence of SCH39166.
(K) Firing frequency changes during application of dopamine and dopamine in the presence of SCH39166, for neurons similar to those illustrated in panel (J).
(L) Firing frequency changes to dopamine application for those neurons that showed a smaller increase in firing to the application of dopamine in the presence of
SCH39166 (yellow), and those that showed a decrease in firing frequency to dopamine in the presence SCH39166 (black). (M) CoV for neurons that showed a
smaller increase in firing to dopamine in the presence of SCH39166 (yellow), and those that showed a decrease in firing frequency to dopamine in the presence of
SCH39166 (black). (N) Significant differences in spike half-width (ms) for those neurons that showed a smaller increase in firing to dopamine in the presence of
SCH39166 (yellow), compared to those that showed a decrease in firing frequency to dopamine in the presence of SCH39166 (black).
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protocol for D1-like and D2-like receptor agonists, to ensure
the responses to these agonists did not undergo sensitization or
desensitization upon repeated exposure.
Next, quinpirole was applied twice (the second application
was carried out after complete washout of the first). In
two experiments, nine VP neurons were identified for analysis,
as they responded to quinpirole. In six of these neurons,
quinpirole significantly (P < 0.05) increased firing (Figure 4F),
while in the other three quinpirole significantly (P < 0.05)
decreased firing (Figure 4G). In all cases, the second application
of quinpirole produced similar effects to the first one, as the
firing frequencies measured during the first and the second
application of quinpirole were not significantly different for any
of the nine neurons (Figures 4H–J). We concluded that repeated
exposure to D2-like receptor agonists elicited similar effects in
VP neurons.
Next, SKF81297 was repeatedly applied (with the second
application after complete wash out of the first) to test if
differences were seen due to repeated exposure (Figure 4K). In
two experiments, seven neurons in the VP were identified for
analysis as they responded to SKF81297. 7/7 neurons in the VP
studied showed a statistically significant (P < 0.05) increase in
firing frequency in response to SKF81297 application. In all cases,
the second application of SKF81297 produced similar effects to
the first one, as the firing frequencies measured during the first
and the second application of SKF81297 were not significantly
different for any of the seven neurons (Figures 4L,M). We
concluded that repeated exposure to D1-like receptor agonists
elicited similar effects in VP neuron.
Role of D1-Like and D2-Like Receptors in
the Modulation of VP Neurons
To dissect out the modulatory effects of D1-like and D2-like
receptors on VP neurons and to confirm the ability to identify the
neuron types based upon spike half-width, dopamine was applied
in the presence of D1-like and D2-like receptor antagonists.
Dopamine was applied twice, first alone and second (after
complete washout of the first application) in the presence of
the D2-like receptor antagonist sulpiride. In two experiments,
23 VP neurons were identified for analysis, as they responded to
dopamine. 16/ 23 of these neurons had a significantly (P < 0.05)
smaller increase in firing in response to dopamine in the presence
of sulpiride than to dopamine alone (Figures 5C,D). On the other
hand, 7/23 of these neurons had a significantly (P < 0.05) larger
increase in firing in response to dopamine in the presence of
sulpiride than to dopamine alone (Figures 5A,B).
In order to ascertain if this effect of sulpiride on the excitatory
effects of dopamine was related to classes of neurons within
the VP, baseline firing frequency (Figure 5E), CoV (Figure 5F)
and spike half-width (Figure 5G) were calculated. There was
no significant (P > 0.05) difference in average baseline firing
frequency for those neurons that had a larger increase in firing
in response to dopamine in the presence of sulpiride, than those
that had a smaller increase in firing in response to dopamine
in the presence of sulpiride. There was also no significant
(P > 0.05) difference in the CoV for those neurons that had a
larger increase in firing in response to dopamine in the presence
of sulpiride, than those that had a smaller increase in firing
in response to dopamine in the presence of sulpiride. On the
other hand, there was a significant (P < 0.05) difference in
the spike half-width for those neurons that had larger increase
in firing in response to dopamine in the presence of sulpiride
0.29 ± 0.01 ms, with a range of 0.25–0.34 ms, than those
that had a smaller increase in firing in response to dopamine
in the presence of sulpiride 0.19 ± 0.01 ms, with a range
of 0.13–0.24 ms. These results proved consistent with those
seen in Figures 2F–H, 3H.
Next, the same experimental protocol was applied as
in Figures 5A,C, but with the D1-like receptor antagonist
SCH39166. In two experiments, 11 VP neurons were identified
for analysis, as they responded to dopamine. 5/11 of these
neurons had a significantly (P < 0.05) smaller increase in firing
in response to dopamine in the presence of SCH39166 than to
dopamine alone (Figures 5H,I). Moreover, 6/11 of these neurons
had a significantly (P < 0.05) inhibitory response to dopamine in
the presence of SCH39166while being excited by dopamine alone
(Figures 5J,K).
In order to ascertain if the responses to dopamine in the
presence of SCH39166 were related to different classes of neurons
within the VP, baseline firing frequency (Figure 5L), CoV
(Figure 5M) and spike half-width (Figure 5N) were calculated.
There was no significant (P > 0.05) difference in average
baseline firing frequency (Figure 5L) for those neurons that
had a smaller increase in firing (yellow) in response to
dopamine in the presence of SCH39166 compared to those that
displayed an inhibitory response to dopamine in the presence
of SCH39166 (black). There was also no significant difference
in CoV (Figure 5M) for those neurons that had a smaller
increase in firing (yellow) in response to dopamine in the
presence of SCH39166 compared to those that displayed an
inhibitory response to dopamine in the presence of SCH39166
(black). On the other hand, there was a statistically significant
(P < 0.05) difference in spike half-width (Figure 5N) between
those neurons that had a smaller increase in firing (yellow)
in response to dopamine in the presence of SCH39166
0.18 ± 0.01 ms, with a range of 0.12–0.23 ms, compared to
those that displayed an inhibitory response to dopamine in the
presence of SCH39166 0.34 ± 0.01 ms (black), with a range of
0.28–0.39 ms. Again, these results proved consistent with those
seen in Figures 2F–H, 3H.
We can conclude that D2-like receptors are responsible
for both excitation and inhibition of VP neurons, and that
these responses are in distinct groups of neurons, displaying
different spike half-width profiles. We can confirm that these
data support the conclusion that those neurons with a longer
spike half-width profile are excited by D1-like receptor agonists
and inhibited by D2-like receptors agonists, while those with
a shorter spike half-width profile are excited by both D1-like
and D2-like receptor agonists. Those neurons excited by both
D1 and D2 agonists and with a shorter spike half-width profile
are referred to as type I neurons, while those neurons inhibited
by D2 agonists with a longer spike half-width profile are referred
to as type II neurons.
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FIGURE 6 | Low Ca2+ aCSF blocks the excitatory effects of D1-like and D2-like receptor agonists but not the inhibitory effects of D2-like receptor agonists.
(A) Excitatory response to SKF81297 application in standard aCSF, which is not present in low Ca2+. (B) Significant differences in firing frequency for
SKF81297 application in low Ca2+ compared to the application of SKF81297 in standard aCSF. (C) Excitatory responses to quinpirole application alone were
occluded in response to quinpirole application in low Ca2+ aCSF. (D) Significant difference in firing frequency for quinpirole application alone compared to quinpirole
application in low Ca2+ aCSF. (E) Inhibitory responses to quinpirole application persevere to quinpirole application in the presence of low Ca2+ aCSF. (F) Firing
frequency responses to quinpirole alone compared to quinpirole application in low Ca2+ aCSF.
D1-Like Receptors Exert Their Effects
Presynaptically, While D2-Like Receptors
Cause Excitation Presynaptically and
Inhibition Postsynpatically
Because of the GABAergic and Glutamatergic inputs of the VP
(Root et al., 2015) and the number of different interneurons,
including cholinergic neurons (Pang et al., 1998; Zaborszky
and Duque, 2000). It could be that D1-like receptors have
their modulatory effects, presynaptically, postsynaptically or
at both points. To identify whether D1-like receptors caused
the increase in firing frequency in VP neurons acting pre-
or postsynaptically, SKF81297 was applied in a solution of
aCSF with low levels of Ca2+, used to block presynaptic
transmission. This was compared to application of SKF81297 in
standard aCSF.
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SKF81297 was applied twice, first in the presence of low
Ca2+ aCSF and second (after complete washout of the first) in
standard aCSF. In two experiments, 7/7 spontaneously active
neurons in the VP showed no significant change in firing
frequency in response to SKF81297 in low Ca2+ conditions
(Figure 6B). However, 5/7 neurons, showed strong significant
(P < 0.05) increases in excitation 2856 ± 1079% in response
to SKF81297 when subsequently applied in standard aCSF
(Figure 6B). These five neurons also showed statistically
significant (P < 0.05) decreases in firing in response to wash-in
of standard aCSF after prolonged exposure to low Ca2+.
We can therefore conclude that D1-like receptors largely have
their effects presynaptically. However, the question remains as
to whether this is through disinhibition, facilitation, or through
another neurochemical mechanism.
Next the D2-like receptor mediated responses were
investigated. D2-like receptor agonists have been shown in
Figure 3 to produce both excitation and inhibition in the firing
of VP neurons. Mengual and Pickel (2002) have shown that
some D2-like receptors are located presynaptically in the VP.
Little else is known about their site of action within the VP. It
was therefore imperative to investigate this further. To clarify
the mechanism of action of D2-like receptors in the VP, and
to investigate how this relates to their dichotomous effects on
firing frequency, the effects of quinpirole in standard aCSF were
compared to those in low Ca2+ aCSF, which was used to block
presynaptic transmission.
From four experiments, 12 neurons were identified in the
VP for analysis that responded to quinpirole application. 8/12 of
these neurons responded with significant (P < 0.05) increases in
firing frequency to the application of quinpirole and 4/12 of these
neurons responded with significant (P < 0.05) decreases in firing
frequency to the application of quinpirole.
Of the eight that were excited by quinpirole application,
6/8 showed non-significant responses to quinipriole application
in the presence of low Ca2+ aCSF, and 2/8 show significant
(P < 0.05) increases in firing frequency to quinpirole application
in the presence of low Ca2+. For these eight neurons, the
application of quinpirole alone produced an average percentage
increase in firing frequency of 111± 34% compared to 42± 11%
for the application of quinpirole in the presence of low Ca2+
(Figure 6D). In 6/8 cases the first application of quinpirole
(alone) produced significantly (P < 0.05) different responses to
the second application (in low Ca2+) as the firing frequencies
measured during the first (alone) and second (in the presence of
low Ca2+) application of quinpirole were significantly different
(Figure 6D). In 2/8 cases the second application of quinpirole
(in low Ca2+) produced similar effects to the first one (alone)
as the firing frequencies measured during the first and second
application of quinpirole, for these two neurons, were not
significantly different.
Of the four that were inhibited by quinpirole application all
four continued to show significant (P < 0.05) decreases in firing
frequency to quinpirole application in the presence of low Ca2+.
For these four neurons, the average decrease in firing frequency
was −65 ± 13% in response to quinpirole application alone and
−67 ± 10% to quinpirole application in the presence of low
Ca2+ (Figure 6F). In all four cases, the second application of
quinpirole (in low Ca2+) produced similar effects to the first one
(alone) as the firing frequencies measured during the first and
second application of quinpirole were not significantly different
(Figure 6F).
We conclude that D2-like receptors mediate an increase in
firing frequency, acting presynaptically in the majority of VP
neurons, while D2-like receptors mediate a decrease in firing
frequency acting postsynaptically in a minority of VP neurons.
D1-Like Receptors Excite VP Neurons
Through Presynaptic Modulation of
Glutamate
Because the VP has both GABAergic and glutamatergic inputs
(Root et al., 2015), these transmitters were potentially involved
in the D1-like receptor agonist action in the VP. As current
research suggests that D1 receptors are located presynaptically
in the VP, and D1-like receptors are largely considered to be
excitatory (Vallone et al., 2000), it seemed possible that they
were modulating glutamatergic inputs and therefore increasing
neuronal firing in the VP via increased release of GA. To test
this hypothesis, SKF81297 was applied twice, first alone and
then in the presence of ionotropic glutamate receptor antagonists
(NBQX and AP5). The second application was carried out after
complete washout of the first.
In two experiments, seven spontaneously active VP neurons
were identified for analysis as they responded to SKF81297.
All seven neurons studied in the VP showed strong significant
(P < 0.05) increases in firing frequency in response to SKF81297
(Figure 7B). However, all seven showed no significant change
in firing frequency in response to NBQX and AP5 application,
and no significant change in firing frequency in response to
subsequent SKF81297 application in the presence of NBQX
and AP5 (Figures 7A,B). In all cases the firing frequencies
measured during the first and the second application of
SKF81297 were significantly (P < 0.05) different. The first
application of SKF81297 produced an average increase in
excitation of 439 ± 144% compared to 6 ± 6% for the second
application of SKF81297 (Figure 7C), in the presence of NBQX
and AP5.
We can therefore conclude that the increase in firing
frequency produced in the VP as a result of D1-like receptor
agonists application is a result of facilitation of presynaptic
glutamate terminals and the subsequent increase in activation of
ionotropic receptors on VP neurons.
Excitatory Effects of D2-Like Receptor
Agonists Require mGluRs
In order to establish the likely neurotransmitter, and receptor
group that quinpirole was modulating to increase firing
frequency in VP neurons, quinpirole was applied in the presence
of MCPG, which is a non-selective mGluR antagonist. Because
the current research has identified that quinpirole has its
excitatory effects by modulation of presynaptic mechanisms
(Figure 6) and D2-like receptors presynaptically are largely
considered inhibitory (Vallone et al., 2000; Mengual and Pickel,
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FIGURE 7 | D1-like receptor mediated excitation requires ionotropic
glutamate receptors. (A) Excitatory responses to SKF81297 application alone
that are no longer present in response to SKF81297 in the presence of NBQX
and AP5. (B) Firing frequency for (ff) seven VP neurons in response to
SKF81297 application and SKF81297 application in the presence of NBQX
and AP5, similar to that illustrated in panel (A). Firing frequency was measured
before the application of SKF81297, during the application of SKF81297, after
a period of wash out, in response to the application of NBQX and AP5 and
finally in response to SKF81297 in the presence of NBQX and AP5.
Responses characterized by significant (P < 0.05) changes in firing frequency
are in gray, the other ones in yellow. (C) Significant differences in firing
frequency (ff) to SKF81297 alone compared to the application of SKF81297 in
the presence of NBQX and AP5.
2002). Our hypothesis was that D2-like receptors might be
modulating glutamate release. Group 2 and 3 mGluRs are
known to be inhibitory (Benarroch, 2008) and therefore provide
a potential mechanism by which presynaptic inhibition of
glutamate by D2-like receptors agonists might disinhibit neurons
in the VP and therefore increase firing frequency in a number of
VP neurons.
In two experiments, 13 VP neurons were identified for
analysis as they responded to quinpirole. All 13 neurons studied
in the VP showed strong significant (P < 0.05) increases in
firing frequency in response to quinpirole. After a period of
wash out a further significant (P < 0.05) change was seen in
9/13 of those neurons studied in response to application of
the non-selective mGluR antagonist MCPG. Subsequently only
4/13 of these neurons showed any significant (P < 0.05) increase
in firing frequency in response to quinpirole in the presence of
MCPG (Figure 8B). In the majority of cases, the first application
of quinpirole resulted in distinctly different responses to the
second, as the firing frequencies measured during the first and
the second application of quinpirole were significantly (P < 0.05)
different for 12/13 neurons (Figure 8A). The first application
of quinpirole producing an average percentage increase in
excitation of 588 ± 232% compared to 41 ± 27% for the
second application of quinpirole, in the presence of MCPG
(Figure 8C).
To further explore the role of mGluRs in the excitatory effects
of D2-like receptor agonists we applied quinpirole alone and
in the presence of MSPG (Figure 8D), which is a selective
antagonists for group 2 and 3 mGlu receptors, which are known
to have inhibitory effects (Nicoletti et al., 2011) and be located
postsynaptically (Petralia et al., 1996).
From three experiments, 11 neurons were identified for
analysis as they responded to quinpirole application. All
11 neurons studied in the VP showed strong significant
(P < 0.05) increase in firing frequency in response to quinpirole.
After a period of wash out a further significant (P < 0.05) change
was seen in 3/11 of those neurons studied in response to MSPG
application. Subsequently only 2/11 of these neurons showed any
significant (P < 0.05) change in firing frequency in response to
quinpirole in the presence of MSPG (Figure 8E). In all cases the
firing frequencies measured during the first (alone) and second
(presence of MSPG) application of quinpirole were significantly
(P < 0.05) different (Figure 8F).
We therefore concluded that D2-like receptors inhibit the
release of glutamate presynaptically, which in turn disinhibits VP
neurons, which express inhibitory group 2/3 mGluRs, increasing
their firing frequency.
Inhibitory Effects of D2-Like Receptor
Agonists Persevere in the Presence of
mGluR Antagonists
While excitation in VP neurons, as a result of quinpirole
application, has been shown in the current study to be modulated
by presynaptic mechanisms (Figures 6C,D). The current study
suggests that inhibition of firing frequency in the minority of VP
neurons is likely to be as a result of postsynaptic /direct inhibition
(Figures 6E,F). This shouldmean thatMCPGhas no effect on the
reduction in firing frequency seen in response to quinpirole.
In three experiments, five VP neurons were identified for
analysis as they responded to quinpirole application. 5/5 of these
neurons measured in the VP displayed significant (P < 0.01)
decreases in firing frequency in response to quinpirole. After a
period of wash outMCPG application evoked significant changes
in firing frequency in 2/5 neurons, subsequently application of
quinpirole in the presence of MCPG evoked a further significant
(P< 0.05) decrease in firing frequency in 5/5 of these VP neurons
(Figure 9A). In the majority of cases, the second application of
quinpirole produced similar effects to the first one, as the firing
frequencies measured during the first and the second application
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FIGURE 8 | Excitatory effects of D2-like receptor agonists require metabotropic glutamate receptors. (A) Excitatory responses to quinpirole that are not present for
the same neuron in response to quinpirole in the presence of MCPG. (B) Changes in firing frequency for 13 VP neurons to application of quinpirole and quinpirole in
the presence of MCPG, similar to that illustrated in panel (A). Firing frequency was measured before the application of quinpirole, during the application of quinpirole,
after wash out of quinpirole, during application of MCPG and finally during the application of quinpirole in the presence of MCPG. Responses characterized by
significant (P < 0.05) changes in firing frequency are in gray, the other ones in yellow. (C) Significant differences in firing frequency in response to quinpirole compared
to quinpirole in the presence of MCPG. (D) Excitatory responses to quinpirole that are not present for the same neuron in response to quinpirole in the presence of
MSPG. (E) Changes in firing frequency for 11 VP neurons to the application of quinpirole and quinpirole in the presence of MSPG, similar to that illustrated in panel
(A). Firing frequency was measured; before the application of quinpirole, during the application of quinpirole, after wash out of quinpirole, during application of MSPG
and finally during the application of quinpirole in the presence of MSPG. Responses characterized by significant (P < 0.05) changes in firing frequency are in gray, the
other ones in yellow. (F) Significant (P < 0.05) differences in firing frequency in response to quinpirole compared to quinpirole in the presence of MSPG.
of quinpirole were not significantly different for 4/5 neurons
(Figures 9B,C). The first application of quinpirole producing
an average percentage inhibition of −69 ± 8% compared to
−66 ± 9% for the second application of quinpirole, in the
presence of MCPG (Figure 9C).
To further ensure that the inhibitory effect of D2-like receptor
agonists was not mediated presynaptically or through mGlu
receptors, we applied quinpirole in the presence of low Ca2+
aCSF and in the presence of low Ca2+ aCSF and MCPG
(Figure 9D).
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FIGURE 9 | Inhibitory effects of D2-like receptor agonists continue in the presence of mGluR antagonists and low Ca2+ aCSF. (A) Inhibitory responses to quinpirole
application alone and in the presence of MCPG. (B) Changes in firing frequency for five VP neurons to application of quinpirole and quinpirole in the presence of
MCPG, similar to that illustrated in panel (A). Firing frequency was measured before the application of quinpirole, during the application of quinpirole, after wash out
of quinpirole, during application of MCPG and finally during the application of quinpirole in the presence of MCPG. Responses characterized by significant (P < 0.05)
changes in firing frequency are in gray, the other ones in yellow. (C) Firing frequency in response to quinpirole compared to quinpirole in the presence of MCPG.
(D) Inhibitory responses to quinpirole application in the presence of low Ca2+ aCSF are repeated in the presence of low Ca2+ aCSF and MCPG. (E) Changes in firing
frequency for three VP neurons to application of quinpirole and quinpirole in the presence of MCPG, similar to that illustrated in panel (A). Firing frequency was
measured; before the application of quinpirole, during the application of quinpirole, after wash out of quinpirole, during application of MCPG and finally during the
application of quinpirole in the presence of MCPG. Responses characterized by significant (P < 0.05) changes in firing frequency are in gray, the other ones in yellow.
(F) Firing frequency in response to quinpirole in low Ca2+ aCSF compared to quinpirole in the presence of low Ca2+ aCSF and MCPG.
From one experiment, three neurons were identified for
analysis. 3/3 displayed significant (P < 0.05) decreases in firing
frequency in response to application of quinpirole. After a period
of wash out 3/3 of the neurons responded with non-significant
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(P> 0.05) changes in response toMCPG application, subsequent
application of the quinpirole in the presence of low Ca2+
and MCPG evoked further significant (P < 0.05) decreases in
firing frequency in 3/3 of the neurons. In all cases, the second
application of quinpirole (in the presence of MCPG and low
Ca2+) produced similar effects to the first one (Figures 9E,F), as
the firing frequencies measured during the first and the second
application of quinpirole were not significantly different for
3/3 neurons.
We can conclude that mGluR are not involved in the
inhibition seen in the VP to quinpirole application.
Excitatory Responses to D1-Like Receptor
Agonists Are Not Effected by mGluR
Antagonists
We have already established that increases in firing frequency
as a result of SKF81297 application are largely modulated
by glutamate and ionotropic glutamate receptors. To ensure
mGluRs do not interfere with this response, experiments
were carried out with SKF81297 in the presence of MCPG
(Figure 10A). From 2 experiments, 11 neurons were identified
for analysis. 10/11 of these neurons were excited (P < 0.05) by
SKF81297 application. After a period of wash out 4/11 neurons
responded with significant (P < 0.05) changes in response
to MCPG application, subsequent application of SKF81297,
evoked a further significant increase in firing frequency
in 11/11 of the VP neurons observed. In the majority of
cases, the second application of SKF81297 (in the presence
of MCPG) produced similar responses to the first one,
as the firing frequencies measured during the first and
the second application of SKF81297 were not significantly
different for 10/11 neurons (Figures 10B,C). The first
application of SKF81297 producing an average percentage
excitation of 322 ± 105% compared to 361 ± 153% for the
second application of SKF81297, in the presence of MCPG
(Figure 10C).
We can therefore rule out the involvement of mGluRs in the
excitation observed in response to SKF81297 in the VP.
DISCUSSION
This study investigated the effects of dopamine on the tonic firing
of VP neurons in vitro. Our data shows that dopamine has dual
effects in the VP, producing increases and decreases in firing
frequency in VP neurons. Two populations of neurons in the VP
were identified based upon their spike half-width profile. Type
I neurons displaying a markedly shorter spike half-width profile
and being excited by both D1-like and D2-like receptor agonists.
This resulted in a net excitatory effect in response to dopamine in
type I neurons. Type II neurons however had a markedly longer
spike half-width profile, were inhibited by D2-like agonists and
excited by D1-like agonists. For type II neurons the net balance
of inhibitory D2-like receptor activation and excitatory D1-like
receptor activation, through application of dopamine, resulted in
a net effect of increased firing rates in some type II neurons and
decreased firing rates in others.
FIGURE 10 | D1-like receptor agonists continue to excite VP neurons in the
presence of MCPG. (A) Excitatory responses to SKF81297 application alone
and in the presence of MCPG. (B) Changes in firing frequency for 11 VP
neurons to application of SKF81297 and SKF81297 in the presence of
MCPG, similar to that illustrated in panel (A). Firing frequency was measured;
before the application of SKF81297, during the application of SKF81297, after
wash out of SKF81297, during application of MCPG and finally during the
application of SKF81297 in the presence of MCPG. Responses characterized
by significant (P < 0.05) changes in firing frequency are in gray, the other ones
in yellow. (C) Firing frequency in response to SKF81297 compared to
SKF81297 in the presence of MCPG.
Presynaptic and Postsynaptic Effects of
Dopamine
Previous studies of the dopaminergic modulation of VP neurons
had been carried out in vivo. These studies showed that
dopamine can exert both excitatory and inhibitory influences
on VP neurons. Electrical stimulation of the VTA or SNc
caused inhibitions or excitations of VP neurons, in a roughly
2:1 ratio (Napier and Maslowski-Cobuzzi, 1994; Mitrovic and
Napier, 2002). Similar responses were observed with local
microiontophoretic applications of dopamine (Napier and
Potter, 1989; Mitrovic and Napier, 2002). Dopamine D1-like and
D2-like receptors are thought to contribute to these responses,
Frontiers in Cellular Neuroscience | www.frontiersin.org 15 August 2018 | Volume 12 | Article 260
Clark and Bracci Dopamine Effects in Ventral Pallidum
however it is unclear, which modulate excitations and which
modulate inhibitions. Maslowski and Napier (1991a) found
D2-like receptor agonists reduced activity in 59% of neurons
studied and that D1-like receptor agonists excited 69% of
neurons. However, Napier and Maslowski-Cobuzzi (1994) data
suggest that D1-like receptor agonists largely produce inhibitions
in VP neurons and D2-like receptor agonist largely produce
excitation.
Both direct and indirect effects of dopamine are considered
likely involved (Root et al., 2015) in modulation of VP
neurons. However, a dissection of these effects and of the other
neurotransmitters involved had not been possible in in vivo
experiments. Our data clearly indicated that D1-like receptors
acted at a presynaptic level, as a D1-like receptor agonist
produced no significant effects in low Ca2+ (a condition in which
synaptic transmission is blocked), even in neurons in which
D1-like receptor agonist had previously elicited strong excitatory
effects when applied in normal Ca2+. Furthermore, we were
able to show that D1-like receptors exerted their presynaptic
effects by increasing ionotropic glutamate receptors activation, as
antagonists of ionotropic glutamate receptors (NBQX and AP5)
also consistently blocked the excitatory effects of D1-like receptor
agonists. Thus, a facilitation of glutamate release from terminals
impinging on VP neurons appears to underlie the excitatory
effects of D1-like receptors in both groups of VP neurons.
On the other hand, D2-like receptors engaged both
presynaptic and postsynaptic mechanisms. Low Ca2+ failed to
block the decreases in firing frequency observed in the neurons
of the second group in response to D2-like receptor agonist
application. Thus, D2-like receptors caused their inhibitory
effects acting postsynaptically on VP neurons of the second
group. However, the excitatory effects of a D2-like receptor
agonist were no longer observed (in neurons of the first group)
in low Ca2+ aCSF, showing that these effects were mediated
presynaptically. A study by Mengual and Pickel (2002) showed
that D2-like receptors are located at presynaptic locations on
GABAergic terminals in the VP. However, the excitatory effects
of D2-like receptor agonists persisted in the presence of GABAA
and GABAB receptor antagonists, showing that they did not
result from inhibition of GABA release. On the other hand, a
broad-spectrum mGluR antagonist completely prevented the
excitatory effects of D2-like receptor agonists. Furthermore, a
ligand that selectively blocks group 1 and group 2 mGluRs also
prevented any excitatory action of D2-like receptor agonists.
These observations suggested that the excitatory effects of
D2-like receptors were caused by inhibition of glutamate release
and reduced postsynaptic activation of inhibitory mGluRs.
mGluRs are present in the VP (Testa et al., 1994) and some
mGluR groups are inhibitory (Anwyl, 1999). There is a paucity
of data on mGluR action within the VP, but Ohishi et al. (1993)
data suggests there is labeling for multiple mGluR in the VP,
including the inhibitory mGluR2 group. They are also a likely
candidate as Holmes et al. (1996) found mGluR2 receptors to be
the mediator of postsynaptic hyperpolarizations within the basal
lateral amygdala.
The observation that NBQX and AP5 did not affect
VP neurons firing but prevented the excitatory effects of
D1 agonists, suggests that the glutamate terminals facilitated by
D1 receptors were not spontaneously active in brain slices. We
tentatively propose that a different set of glutamate terminals
was responsible for the activation of postsynaptic inhibitory
mGluRs in those VP neurons in which mGluR antagonists
prevented inhibition by D2 agonists (as illustrated in Figure 11).
These terminals are expected to release glutamate spontaneously,
keeping postsynaptic inhibitory group 2 and/or 3 mGluRs in a
state of basal activation. However, the lack of effects of mGluR
antagonists on the firing frequency of these VP neurons was
unexpected. It is possible that the excitatory influence caused by
reduced activity of mGluRs was compensated by an inhibitory
influence caused by reduced activity of other pre or postsynaptic
mGluRs affecting VP neurons through different mechanisms.
Further experiments will be needed to test this hypothesis.
Identity of VP Neurons Modulated by
Dopamine
As mentioned above, VP neurons displayed two distinct
responses to D1-like and D2-like receptor agonists. Type I
neurons responded with increases in firing frequency to both
specific D1-like and D2-like receptor agonists, while type II
FIGURE 11 | A minimal model explaining the differential effects of D1-like and
D2-like receptor activation on type I and type II VP neurons in the VP. (A)
Presynaptic D1-like receptors facilitate glutamate release and excite type I VP
neurons through increased activation of ionotropic glutamate receptors.
Another glutamatergic input to type I neurons activates inhibitory metabotropic
glutamate receptors. Presynaptic D2-like receptors have an inhibitory effect on
this glutamate input, reducing glutamate release and disinhibiting type I
neurons. Thus, both D1-like and D2-like receptor have excitatory influences on
type I neurons. (B) Presynaptic D1-like receptors facilitate glutamate release
and excite type II VP neurons by increasing activation of ionotropic glutamate
receptors. Postsynaptic D2-like receptors have direct inhibitory effects on type
II VP neurons. The net influence of dopamine on type II neurons results from
the balance of excitatory D1-like receptor effects and inhibitory D2-like
receptor effects.
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neurons were excited by D1-like receptor agonists and inhibited
by D2-like receptor agonist. These responses can be attributed
unambiguously to two distinct neuronal populations based on
their spike half-width profile, with the type I neurons having a
shorter spike half-width than type II neurons.
Further supporting this distinction, neurons with a shorter
spike half-width displayed a decreased increase in firing
frequency to dopamine in the presence of either D1-like or
D2-like receptor antagonists, suggesting that both receptor
classes contributed to increases in firing frequency for these
neurons. Conversely, neurons with a longer spike half-width
showed an increased excitatory response to dopamine in the
presence of D2-like receptor antagonists and were inhibited
by the application of dopamine in the presence of D1-like
receptor antagonists, confirming that D2-like receptors inhibit
these neurons.
Several studies have investigated spike half-width profiles in
the VP and its dorsal extent, the GPe (Bengtson and Osborne,
2000; Bengtson et al., 2004; Abdi et al., 2015; Hernández
et al., 2015). VP neurons include prominent cholinergic and
GABAergic populations (Zaborszky and Duque, 2000; Duque
et al., 2007; Root et al., 2015). Cholinergic cells have sparse
axons and project to the cortex and the amygdala (Zaborszky
et al., 1986; Carlsen et al., 2004), while GABAergic neurons can
have dense axonal arborization and are thought to include both
interneurons and projection neurons (Zaborszky et al., 2012).
The electrophysiological features of these neuronal types have
not been completely identified. Bengtson and Osborne (2000)
found that only 2/13 cholinergic neurons in the VP had any
tonic firing activity. Bugaysen et al. (2010) suggested that it is
impossible to separate neuron populations from extracellular
recordings in the rat GPe based on action potential half-width,
although Becchetti et al. (2012) suggests that spike half-width
maybe a viable way of distinguishing inhibitory from excitatory
neurons in mature animals using MEA data.
Pang et al. (1998) identified ‘‘Type I’’ neurons in vivo, with
features resembling those of noncholinergic neurons described
by Bengtson and Osborne (2000). Type B neurons of Lavin
and Grace (1996) also have features similar to these cells, and
have short spike duration (approximately 1.3 ms). These neurons
are probably GABAergic projection neurons (Root et al., 2015).
Conversely, ‘‘Type II’’ neurons of Pang et al. (1998) and ‘‘Type A’’
neurons of Lavin and Grace (1996) had relatively similar features,
including slower spikes (approximately 2.8ms). Pang et al. (1998)
identified these neurons as noncholinergic (possibly GABAergic)
interneurons. Based on this complex picture, we can tentatively
classify our type I neurons as GABAergic projection neurons
corresponding to type I of Pang et al. (1998) and type B of
Lavin and Grace (1996) and our type II neurons as GABAergic
interneurons corresponding to type II of Pang et al. (1998) and
type A of Lavin and Grace (1996). Further investigation is needed
to confirm the neurochemical and morphological identity of the
two groups of neurons identified by this study based on their
dopaminergic responses.
In some previous in vivo experiments dopamine inhibitions
of VP neurons were more frequent than dopamine excitations
(Napier and Maslowski-Cobuzzi, 1994), while we found a
prevalence of excitations. It is likely that this discrepancy results
from the fact that in the intact brain the VP receives a number
of external inputs (including glutamate) that are silent in brain
slices and could be modulated presynaptically by dopamine.
Functional Implications
The VP is crucially involved in reward processing (Smith et al.,
2009) and drug-seeking behavior (Kalivas and Volkow, 2005;
Prasad and McNally, 2016). Dopamine levels rise dramatically
within the VP as a result of sensitization to drugs of abuse (Stout
et al., 2016) and dopaminergic mechanisms in the VP underlie
morphine-induced conditioned place preferences (Gong et al.,
1996; Zarrindast et al., 2007). The current study provides
novel and clear insights into the cellular mechanisms by which
dopamine modulate neuronal activity in the VP. Given the
prominence of the VP in the reward circuits, understanding how
dopamine works in this area is of primary theoretical value, and
can also help developing rational pharmacological approaches to
fight addiction and other dysfunctions of the reward system.
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